Skip to main content
CORESTEMCHEMON Inc. logo

CORESTEMCHEMON Inc. — Investor Relations & Filings

Ticker · 166480 ISIN · KR7166480004 KO Professional, scientific and technical activities
Open in API
Filings indexed 274 across all filing types
Latest filing 2022-09-06 M&A Activity
Country KR South Korea
Listing KO 166480

About CORESTEMCHEMON Inc.

https://www.corestemchemon.com/eng/main…

CORESTEMCHEMON Inc. is a biotechnology company operating through two main divisions: a biopharmaceutical unit and a non-clinical Contract Research Organization (CRO) unit. The biopharmaceutical division is dedicated to the research and development of new drugs based on stem cell therapy technology. Its clinical pipeline primarily targets neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), cerebellar ataxia, and multiple sclerosis, as well as autoimmune diseases like systemic lupus erythematosus (SLE) and fibrosis. The non-clinical CRO division provides comprehensive preclinical services, conducting essential toxicity and efficacy evaluations for pharmaceuticals, biopharmaceuticals, cosmetics, and medical devices to support regulatory approval processes.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(회사합병결정)
M&A Activity Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a corporate merger (회사합병 결정) between Corestem Co., Ltd. and Chemon Co., Ltd. It details the merger ratio, rationale, impact on shareholders, and the timeline for the merger process. This type of document is a formal regulatory filing concerning M&A activity. While it contains detailed information, it is a specific regulatory disclosure required by the Korea Exchange (KRX) for material corporate events, fitting the 'M&A Activity' (TAR) category.
2022-09-06 Korean
[기재정정]투자설명서
M&A Activity Classification · 1% confidence The document is a '투자설명서' (Investment Prospectus) regarding a merger between Corestem Co., Ltd. and Chemon Co., Ltd. It details the merger purpose, conditions, risk factors, and financial information. In the context of financial filings, a prospectus related to a merger or capital change is classified as a Proxy Solicitation & Information Statement (PSI) because it provides shareholders with the necessary information to evaluate the merger and vote on it.
2022-09-06 Korean
투자설명서
Share Issue/Capital Change Classification · 1% confidence The document is a '투자설명서' (Investment Prospectus) filed by Corestem Co., Ltd. regarding a merger with ChemOn Co., Ltd. It contains detailed information about the merger, risk factors, financial status, and share issuance details. In the context of financial filings, a prospectus related to a merger or capital change is classified as a Proxy Solicitation & Information Statement (PSI) as it provides shareholders with the necessary information to evaluate the transaction and vote on it.
2022-09-05 Korean
[기재정정]증권신고서(합병)
M&A Activity Classification · 1% confidence The document is a '증권신고서(합병) 정정신고' (Amendment to Securities Registration Statement for Merger) filed by Corestem Co., Ltd. It details corrections to a previously submitted merger registration statement, including updates to key schedules, risk factors, and financial information related to the merger. This is a formal regulatory filing required for corporate mergers and does not fit into the other specific categories like '10-K' (Annual Report) or 'ER' (Earnings Release). It is a primary regulatory document, not an announcement of a report.
2022-08-24 Korean
반기보고서 (2022.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-annual Report) for Corestem Co., Ltd., covering the period from January 1, 2022, to June 30, 2022. It contains detailed financial information, business operations, management discussions, and governance details, which are characteristic of an interim financial report. It is not an announcement of a report, but the report itself. H1 2022
2022-08-16 Korean
주권매매거래정지(합병)
Delisting Announcement Classification · 1% confidence The document is a short, official notice regarding the suspension of stock trading ('주권매매거래정지') for a company due to a merger ('합병'). It cites specific exchange regulations and provides the duration of the suspension. Since it is a regulatory announcement regarding trading status and does not fit into specific categories like M&A (which would be a deal announcement) or a full report, it falls under the general regulatory filing category.
2022-08-16 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.